DEL ROSSO, J.; KIRCIK, L. .; STEIN GOLD, L.; BALDWIN, H. .; WEISS, J. .; PARISER, D.; CALLENDER, V. .; LAIN, E. .; GOLD, M.; BEER, K. .; DRAELOS, Z.; SADICK, N.; PILLAI, ; R.; BHATT, V.; TANGHETTI, E. Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Phase 2 Study of the First Triple-Combination Drug. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 2, p. s17, 2022. DOI: 10.25251/skin.6.supp.17. Disponível em: https://jofskin.org/index.php/skin/article/view/1534. Acesso em: 8 aug. 2022.